Biosafety of Mesoporous Silica Nanoparticles

Biosafety of Mesoporous Silica Nanoparticles

Careful analysis of any new nanomedicine device or disposal should be undertaken to comprehensively characterize the new product before application, so that any unintended side effect is minimized. Because of the increasing number of nanotechnology-based drugs, we can anticipate that regulatory auth...

Full description

Bibliographic Details
Main Authors: Estelle Rascol, Cédric Pisani, Christophe Dorandeu, Jeff L. Nyalosaso, Clarence Charnay, Morgane Daurat, Afitz Da Silva, Jean-Marie Devoisselle, Jean-Charles Gaillard, Jean Armengaud, Odette Prat, Marie Maynadier, Magali Gary-Bobo, Marcel Garcia, Joël Chopineau, Yannick Guari
Format: Article
Language:English
Published: MDPI AG 2018-08-01
Series:Biomimetics
Subjects:
nanoparticles
safety
mesoporous silica
protein corona
internalization
adverse outcome pathways
Online Access:http://www.mdpi.com/2313-7673/3/3/22

Internet

http://www.mdpi.com/2313-7673/3/3/22

Similar Items